White House announces first 10 medicines subject to Medicare price negotiations championed by Klobuchar

Medications that prevent blood clots and help patients with diabetes will be among the first 10 drugs subject to price negotiations between the federal government and drug manufacturers. The U.S. Department of Health and Human Services on Tuesday announced the list of 10 medications , saying Medicare enrollees paid a total of $3.4 billion in out-of-pocket costs for the drugs during 2022. Initiated by federal legislation last year, the new program for price negotiations has been touted by Democrats as a way to deliver big savings for both seniors and...